1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-04-02
DOI
10.1002/ijc.31417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
- (2017) Lieve Brochez et al. EUROPEAN JOURNAL OF CANCER
- IDO1: An important immunotherapy target in cancer treatment
- (2017) Fangxuan Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition
- (2017) Jinfeng Pan et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Dysplasia and colorectal cancer surveillance in inflammatory bowel disease
- (2017) Samba Siva Reddy Pulusu et al. Expert Review of Gastroenterology & Hepatology
- CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma
- (2015) Yozo Mitsui et al. BMC CANCER
- Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production
- (2015) Sarvenaz Metghalchi et al. Cell Metabolism
- Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt
- (2015) Justin E Wilson et al. NATURE MEDICINE
- Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis
- (2015) A. L. Geis et al. Cancer Discovery
- Development of 1-N-11C-Methyl-l- and -d-Tryptophan for pharmacokinetic imaging of the immune checkpoint inhibitor 1-Methyl-Tryptophan
- (2015) Lin Xie et al. Scientific Reports
- Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers
- (2015) Paolo Puccetti et al. PLoS One
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Mitosis and apoptosis: how is the balance set?
- (2013) Caroline H Topham et al. CURRENT OPINION IN CELL BIOLOGY
- IDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in Mice
- (2013) Ameet I. Thaker et al. GASTROENTEROLOGY
- GCN2-Dependent Metabolic Stress Is Essential for Endotoxemic Cytokine Induction and Pathology
- (2013) H. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase
- (2012) Kengo Ogawa et al. CANCER SCIENCE
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
- (2012) L. Pilotte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
- (2012) Richard Metz et al. OncoImmunology
- Molecular Genetics of Colorectal Cancer
- (2011) Eric R. Fearon Annual Review of Pathology-Mechanisms of Disease
- Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
- (2011) L Ferdinande et al. BRITISH JOURNAL OF CANCER
- A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity
- (2011) Huei-Jiun Yang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
- (2011) Christiane A. Opitz et al. PLoS One
- The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation
- (2010) Jiangbin Ye et al. EMBO JOURNAL
- Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction
- (2010) G. Matteoli et al. GUT
- Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
- (2009) Feng Qian et al. CANCER RESEARCH
- The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
- (2009) Yan-Fang Gao et al. Journal of Translational Medicine
- IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
- (2008) Stefan Löb et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Nampt: linking NAD biology, metabolism and cancer
- (2008) Antje Garten et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now